Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries said Sunday that its ordinary general meeting (OGM) has approved the estimated budget and investment plan for fiscal year 2017/2018.
The company targets an increase of 28.6% in profits for FY17/18, and set the investment budget for the year at EGP 10.3 million, according to a bourse filing.